Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.
Also called NCT05096442
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 204 participants
- Sponsor
- Registry
-
NCT05096442
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05096442. Randomized; single masking; primary purpose treatment. Start 2021-09-30 (actual); primary completion 2023-06-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
- Condition
- Coronary Artery Disease
- Intervention (Device)
- GENOSS® DCB
- Intervention (Device)
- SeQuent® Please NEO
- Lead sponsor
- Genoss Co., Ltd.
Record details
- Record id
cardio:ct-nct05096442- Content hash
01a3e1e93c3ffa1ebe9266bf81eade9e8b490f09993b97fdc49eb61c2aaf4b9a